IDEAYA Biosciences Inc (NASDAQ:IDYA)
| 25.51 Delayed Data As of Jun 09 |  -0.02 / -0.08%Today’s Change | 9.00 Today|||52-Week Range 25.76 | +40.40% Year-to-Date |
Latest IDYA News | Press Releases
No recent news for IDEAYA Biosciences Inc.
Today’s Trading
| Previous close | 25.53 |
| Today’s open | 25.61 |
| Day’s range | 25.10 - 25.74 |
| Volume | 6,888 |
| Average volume (3 months) | 589,614 |
| Market cap | $1.4B |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -0.26% |
| Earnings growth (this year) | -45.07% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +82.28% |
| P/E ratio | NM |
| Price/Sales | 14.79 |
| Price/Book | 3.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNDXSyndax Pharmaceutica... | -0.17 | -0.80% |
| AGIOAgios Pharmaceutical... | -0.71 | -2.67% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 14, 2023 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $50.9M |
| Annual profit (last year) | -$58.7M |
| Net profit margin | -115.17% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
